A jaw-dropping report from the
Globe and Mail:
Ottawa got last-minute warning of shortfall in H1N1 vaccine. Excerpt:
Canada's vaccine manufacturer did not inform federal health officials until Thursday that the number of H1N1 doses available to Canadians next week would shrink by much more than half – prompting provinces to suspend the rollout of the vaccine to the general public for at least a couple of weeks.
GlaxoSmithKline is forecast to ship 436,000 doses to provinces and territories, far less than the roughly two million anticipated, because it had to interrupt production at its Ste-Foy, Que., plant to make a version of the vaccine for pregnant women.
The last-minute admission of a shortfall is the latest and largest blow in a week marked by anxiety, confusion and mounting frustration. Problems with vaccine supply and underestimation in pandemic planning now threaten to undermine Canada's largest-ever inoculation campaign.
What's gone wrong?
It's a story of slower-than-expected vaccine production, a resurgent virus targeting the young, and a once-skeptical public suddenly rushing to get the shot.
As flu clinics prepared to open this week, rising anti-vaccination sentiment persuaded health officials that uptake would be low, prompting them to step up their campaign to persuade Canadians to be immunized.
What they didn't count on was the far more compelling effect of real-world events – the deaths of two seemingly healthy young Canadians. Panicked, parents hurried children of all ages to flu-shot clinics; healthy adults went too, ignoring the carefully planned protocol that the most vulnerable should come first.
And now this: the shortage that David Butler-Jones, Canada's Chief Public Health Officer, said the government only learned the extent of late Thursday.
Thursday? As in,
yesterday? When I saw Butler-Jones and Health Minister Aglukkaq here in Vancouver
a couple of weeks ago, they were sticking to "early November" as the roll-out date for the vaccine. They'd said the same thing in an
earlier press conference from Iqaluit.
Both were so resistant to reporters' questions about an earlier vaccination start that I thought something sounded wrong. Then, without much explanation, the vaccinations started a week early after all.
In fairness, Dr. Butler-Jones is an old pro. He may simply have known from experience that pharmaceutical companies can't always be trusted to deliver the goods. Early November was a reasonable launch date, so he stuck to it.
But two kids' deaths, and resulting political pressure, forced the Canadian government to launch early, and GSK didn't have the vaccine in adequate quantities.
Professional soldiers remind each other that the battle plan is what disappears in the first moment of contact with the enemy. Evidently the same is true of pandemic plans.
Still, you would think that public-health professionals would know how much can go terribly wrong in any disease outbreak. What was their Plan B? And if they didn't have a Plan B, what's their excuse?
Recent Comments